InvestSMART

Noumi Limited (ASX:NOU)

ALERT: Price-sensitive ASX Announcement for NOU
Current share price for NOU : $0.123 0.003 (2.08%)+
Release
20 Aug 2026 8:57AM
Price at Release
$0.120
Full Release
download
Summary
Noumi Limited's FY26 results showcased significant growth and strategic advancements despite external challenges. The company reported a 94.1% increase in Dairy & Nutritionals adjusted operating EBITDA, driven largely by favorable commodity prices. Milklab's brand revenue also grew significantly, with a notable increase in both export and retail markets. Despite these gains, Noumi reported a net loss after tax of $67.2 million, although this was a marked improvement from the previous year. Strategic initiatives included a proposed Share and Option Schemes with Arrovest to manage Convertible Notes maturity, and an ongoing focus on expanding dairy product lines and improving production efficiency. The company moves into FY27 with strengthened operations and a focus on disciplined improvement, while maintaining a diverse brand portfolio that includes Milklab, Australia’s Own, and others.
Key Points
  • Dairy & Nutritionals adjusted operating EBITDA increased by 94.1% to $21.6 million due to commodity price tailwinds.
  • Milklab brand revenue grew by 5.5%, with export sales increasing by 11.2% and retail revenue by 44.6%.
  • Cash generated from trading activities increased by 3.2% to $69.1 million.
  • Net revenue increased by $52.5 million, with total net revenue at $648.4 million.
  • Noumi Limited reported a statutory net loss after tax of $67.2 million, an improvement of $82.8 million from the previous year.
  • Noumi announced a proposed Share and Option Schemes with Arrovest to address Convertible Notes maturity.
  • The company focuses on expanding dairy product lines and improving production performance.
  • Milklab's domestic retail performance increased by 44.6% and now accounts for 17.0% of its Australian sales.
  • Noumi has a comprehensive portfolio of brands including Milklab, Australia’s Own, Uprotein, and Vital Strength.
  • Noumi Limited enters FY27 with a stronger operational platform and clear priorities for improvement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.